A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

NCT02491268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Cilostazol
DRUG: Placebo

Sponsor

National Cerebral and Cardiovascular Center, Japan